Tizanidine Tablet
Product Images NDC 72162-1642
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidine (NDC 72162-1642). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Tizanidine-2 (Tizanidine 2)
Tizanidine-3 (Tizanidine 3)
Tizanidine-4 (Tizanidine 4)
Label (Lbl721621642)
This text appears to be a description of a medication called Tizanidine Tablets, USP. Each tablet contains 4.567 mg of Tizanidine HCI, equivalent to 4 mg of Tizanidine base. The medication should be kept out of the reach of children and stored at a temperature of 25°C (77°F), with excursions permitted between 15° to 30°C (59° to 86°F). It should be dispensed in a tight, light-resistant container with a child-resistant closure. The text also mentions that Tizanidine Tablets are not interchangeable with Tizanidine capsules. The NDC (National Drug Code) for this medication is 72162-1642-0. It is intended for prescription use only and is manufactured by ALKALOIDA Chemical Company Zrt and relabeled by Bryant Ranch Prepack, Inc.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.